Cargando…
Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
Background: There is a lack of biomarkers for predicting the efficacy of immunotherapy in triple-negative breast cancer (TNBC). Hence, we constructed an immune risk score (IRS) model to predict the prognosis of patients with TNBC and evaluate those who are sensitive to immunotherapy. Methods: The ri...
Autores principales: | Sun, Xiaorui, Zhang, Tiansong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701826/ https://www.ncbi.nlm.nih.gov/pubmed/36452159 http://dx.doi.org/10.3389/fgene.2022.1067254 |
Ejemplares similares
-
Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer
por: Liu, Ji, et al.
Publicado: (2022) -
Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
por: Loizides, Sotiris, et al.
Publicado: (2023) -
Identification of ubiquitination-related gene classification and a novel ubiquitination-related gene signature for patients with triple-negative breast cancer
por: Zhao, Kankan, et al.
Publicado: (2023) -
Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
por: Yao, Zhihao, et al.
Publicado: (2022) -
RUNX regulated immune-associated genes predicts prognosis in breast cancer
por: Fu, Jingyue, et al.
Publicado: (2022)